Status:
UNKNOWN
Myopia-control Efficacy by Peripheral Defocus Lens (PDL)
Lead Sponsor:
Tianjin Eye Hospital
Conditions:
Myopia, Progressive
Eligibility:
All Genders
6-15 years
Phase:
NA
Brief Summary
The proposed study below aims to assess the effect of customized Bestivue PDL lenses on retinal image quality and myopia control. A total of 160 subjected would be enrolled in and randomized to allcoa...
Detailed Description
The proposed study below aims to assess the short-term and long-term effect of customized Bestivue PDL lenses on retinal image quality and myopia control. To these ends, two stages of testing are plan...
Eligibility Criteria
Inclusion
- The subjects had spherical RE of -1.00 to -6.00 D
- Astigmatism ≤ 4.00 D
- Anisometropia ≤ 1.50 D\\
- Best corrected visual acuity (BCVA) equal to or better than logMAR 0.0 (20/20) in both eyes.
Exclusion
- Strabismus
- Ocular limitations
- Systemic abnormalities affecting vision and ocular motility.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05373693
Start Date
July 1 2019
End Date
September 30 2022
Last Update
May 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin Eye Hospital
Tianjin, China, 300020